- 专利标题： A CONNECTIVE TISSUE GROWTH FACTOR (CTGF) INHIBITOR FOR USE IN THE TREATMENT OF MUSCULAR DYSTROPHIES
-
申请号： EP20176176.4申请日： 2020-05-22
-
公开(公告)号： EP3741389A1公开(公告)日： 2020-11-25
- 发明人: ELMANKABADI, Bassem , YU, Kin-Hung Peony , KOUCHAKJI, Elias , SEKAYAN, Tro
- 申请人： Fibrogen, Inc.
- 申请人地址： 409 Illinois Street San Francisco, CA 94158 US
- 专利权人： Fibrogen, Inc.
- 当前专利权人： Fibrogen, Inc.
- 当前专利权人地址： 409 Illinois Street San Francisco, CA 94158 US
- 代理机构： Wise, Daniel Joseph
- 优先权： US201962852227P 20190523; US201962863143P 20190618
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; A61P9/00 ; A61P11/00 ; A61P21/00
摘要：
The invention relates to methods and agents useful for treating muscular dystrophies (MDs), in particular, Duchenne muscular dystrophy (DMD). Methods and agents for treating various physiological and pathological features associated with muscular dystrophies are also provided.
信息查询
